科美诊断(688468) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥118,200,615.01, representing a decrease of 6.23% compared to the same period last year[2]. - The net profit attributable to shareholders for Q3 2024 was ¥35,508,858.96, down 18.57% year-over-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥24,129,454.47, a decline of 42.01% compared to the previous year[2]. - Total operating revenue for the first three quarters of 2024 was CNY 343,786,670.77, a decrease of 0.14% compared to CNY 345,267,780.87 in the same period of 2023[14]. - Operating profit for the first three quarters of 2024 was CNY 128,141,009.06, down 6.67% from CNY 136,508,794.26 in the previous year[15]. - Net profit for the first three quarters of 2024 was CNY 112,150,960.47, compared to CNY 120,238,363.98 in the same period of 2023, reflecting a decline of 6.71%[15]. - The net profit for Q3 2024 was CNY 112,150,960.47, a decrease from CNY 120,238,363.98 in Q3 2023, representing a decline of approximately 9.1%[16]. - The basic and diluted earnings per share for Q3 2024 were both CNY 0.28, down from CNY 0.30 in Q3 2023, indicating a decrease of 6.7%[16]. Research and Development - The total R&D investment for Q3 2024 was ¥19,674,235.17, which is a decrease of 8.24% year-over-year[4]. - The R&D investment as a percentage of operating revenue was 16.64%, down 0.37 percentage points from the previous year[4]. - Research and development expenses for the first three quarters of 2024 were CNY 48,830,331.80, slightly up from CNY 47,237,479.89 in the same period of 2023[15]. - Research and development expenses for the third quarter were CNY 23,156,500.08, down 16.7% from CNY 27,827,230.08 in the same quarter of 2023[22]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,838,627,332.99, reflecting a 0.99% increase from the end of the previous year[4]. - The total assets as of the end of Q3 2024 were CNY 1,838,627,332.99, slightly up from CNY 1,820,562,566.47 at the end of Q3 2023[13]. - Non-current liabilities increased to CNY 253,194,767.84, up from CNY 237,625,811.64 year-over-year[13]. - The total liabilities also decreased to CNY 12,147,984.14 from CNY 15,839,511.51, a reduction of 23.5%[20]. - The company's total equity increased to CNY 1,401,383,380.45, compared to CNY 1,388,801,768.59 in the previous year, reflecting a growth of 0.68%[13]. - The total equity decreased to CNY 1,015,173,147.72 from CNY 1,101,780,041.09, a reduction of 7.9%[20]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥135,334,103.57, showing an increase of 8.97% compared to the previous year[2]. - Cash flow from operating activities for the first three quarters of 2024 was CNY 135,334,103.57, an increase from CNY 124,199,391.92 in the same period of 2023, reflecting a growth of about 8.2%[17]. - The cash inflow from operating activities totaled 1,541,534.72 RMB for the first three quarters of 2024, down from 2,940,714.64 RMB in 2023, indicating a decline of about 47.6%[23]. - The company reported cash inflow from sales of goods and services of CNY 396,944,345.39 for the first three quarters of 2024, slightly down from CNY 397,025,380.77 in the same period of 2023[17]. - The net cash flow from investment activities for Q3 2024 was -CNY 97,854,240.68, an improvement from -CNY 200,962,217.69 in Q3 2023[18]. - The total cash inflow from investment activities in the first three quarters of 2024 was CNY 1,546,734,544.15, compared to CNY 1,830,639,554.31 in the same period of 2023, showing a decrease of approximately 15.5%[17]. - The net cash flow from investment activities for the first three quarters of 2024 was 60,869,492.92 RMB, compared to 67,392,389.11 RMB in 2023, showing a decline of about 9.3%[23]. - The cash outflow from financing activities totaled 100,415,312.61 RMB, compared to 148,016,343.76 RMB in the same period last year, representing a decrease of approximately 32.2%[24]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 9,758[8]. - The top shareholder, Ningbo Free Trade Zone Yingweili Enterprise Management Partnership, holds 108,000,008 shares, representing 26.93% of total shares[8]. - The company’s repurchase account holds 6,514,913 shares, representing 1.62% of total shares as of September 30, 2024[9]. - There are no significant changes in the relationships among the top ten shareholders[9]. - The company has not reported any changes in the participation of major shareholders in margin trading and securities lending[10]. Investment and Financial Activities - The company reported non-recurring gains of ¥11,379,404.49 for the current period, with significant contributions from government subsidies and asset disposals[6]. - The decline in net profit attributable to shareholders after deducting non-recurring gains was primarily due to the implementation of industry procurement policies, leading to a decrease in revenue[7]. - The company reported an investment income of CNY 27,224,451.17, significantly lower than CNY 58,544,898.77 in the previous year, indicating a decrease of 53.6%[22]. - The company's financial expenses showed a significant change, with a net financial income of CNY -5,532,102.06 compared to CNY -3,629,078.20 in the previous year[22]. - The company distributed dividends and interest payments totaling 49,324,144.36 RMB in Q3 2024, significantly lower than 139,147,001.90 RMB in Q3 2023, indicating a reduction of about 64.6%[24].